X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-06 | HNVR | Golden Robert | Dir | S - Sale | $26.34 | -5,197 | 439,719 | -1% | -$136,902 | |||||
| M | 2025-02-04 | HNVR | Golden Robert | Dir | S - Sale | $26.64 | -5,681 | 444,916 | -1% | -$151,314 | |||||
| M | 2025-01-31 | HNVR | Golden Robert | Dir | S - Sale | $26.63 | -4,772 | 450,597 | -1% | -$127,074 | |||||
2024-12-10 | HNVR | Katz Michael David M.D. | Dir | S - Sale | $25.53 | -5,000 | 246,104 | -2% | -$127,650 | ||||||
2024-12-10 | HNVR | Golden Robert | Dir | S - Sale | $25.50 | -2,500 | 454,038 | -1% | -$63,750 | ||||||
2024-11-22 | HNVR | Sisti Elena | Dir | P - Purchase | $23.48 | +215 | 153,111 | 0% | +$5,048 | ||||||
2024-08-20 | HNVR | Okun Philip A | Dir | P - Purchase | $17.14 | +100 | 39,746 | 0% | +$1,714 | ||||||
| M | 2024-06-13 | HNVR | Okun Philip A | Dir | P - Purchase | $16.48 | +1,000 | 39,646 | +3% | +$16,480 | |||||
| M | 2024-06-11 | HNVR | Okun Philip A | Dir | P - Purchase | $16.26 | +1,000 | 38,646 | +3% | +$16,255 | |||||
2024-05-03 | HNVR | Burke Lance P | EVP, CFO | P - Purchase | $16.61 | +175 | 21,946 | +1% | +$2,907 | ||||||
| M | 2024-05-01 | HNVR | Burke Lance P | EVP, CFO | P - Purchase | $16.62 | +400 | 21,771 | +2% | +$6,648 | |||||
2024-04-30 | HNVR | Wilcox McClelland W | Pres | P - Purchase | $16.60 | +250 | 81,537 | 0% | +$4,150 | ||||||
2024-04-30 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $16.60 | +500 | 278,388 | 0% | +$8,300 | ||||||
2024-04-30 | HNVR | Burke Lance P | EVP, CFO | P - Purchase | $16.60 | +200 | 21,371 | +1% | +$3,320 | ||||||
2024-04-24 | HNVR | Burke Lance P | EVP, CFO | P - Purchase | $16.78 | +200 | 21,171 | +1% | +$3,356 | ||||||
2024-04-24 | HNVR | Vivona John P | FSVP, Chief Risk Officer | P - Purchase | $16.79 | +200 | 3,200 | +7% | +$3,357 | ||||||
| M | 2024-04-23 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $16.84 | +400 | 277,888 | 0% | +$6,736 | |||||
2024-04-22 | HNVR | Sisti Elena | Dir | P - Purchase | $16.95 | +2,000 | 152,896 | +1% | +$33,900 | ||||||
2024-04-22 | HNVR | Wilcox McClelland W | Pres | P - Purchase | $16.91 | +200 | 81,287 | 0% | +$3,382 | ||||||
2024-04-22 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $16.58 | +200 | 277,488 | 0% | +$3,316 | ||||||
2024-01-31 | HNVR | Golden Robert | Dir | P - Purchase | $18.00 | +500 | 454,421 | 0% | +$9,000 | ||||||
2024-01-29 | HNVR | Sisti Elena | Dir | P - Purchase | $18.01 | +2,750 | 148,779 | +2% | +$49,528 | ||||||
2024-01-29 | HNVR | Katz Michael David M.D. | Dir | P - Purchase | $18.02 | +700 | 241,930 | 0% | +$12,614 | ||||||
2023-12-08 | HNVR | Okun Philip A | Dir | S - Sale | $17.75 | -1,124 | 32,328 | -3% | -$19,954 | ||||||
2023-11-08 | HNVR | Sisti Elena | Dir | P - Purchase | $18.00 | +265 | 146,029 | 0% | +$4,770 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |